Pagano et al. demonstrated in a murine model that IL-27 deficiency promoted a more immunosuppressive tumour microenvironment and accelerated CLL progression; however, their study did not specifically address the impact of IL-27 on TIM-3 expression [17]. Here, IL27 is linked to B-cell chronic lymphocytic leukemia.